Trial of CXD and Ketogenic Diet for MASLD Shows Structured Approach
A clinical trial is underway to evaluate the efficacy of CXD combined with a restrictive ketogenic diet in treating MASLD.
Asset / Drug
Drug and asset intelligence for MASLD with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.